-+ 0.00%
-+ 0.00%
-+ 0.00%

ALTIMMUNE - 52-WEEK DATA READOUT FROM PERFORMA PHASE 3 TRIAL ANTICIPATED IN 2029

Reuters·08/03/2026 12:00:01

Please log in to view news